Top Markets
Coin of the day
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPHW
Rankning i aktier #39800
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical... Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.
Aktiekurs
$0.003
Senast synkroniserad: 2025-12-12
Marknadsvärde
$343.91K
Förändring (1 dag)
-16.67%
Förändring (1 år)
-90.23%
Land
US
Handel Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Kategori

Aktiekurshistorik för Reviva Pharmaceuticals Holdings, Inc. (RVPHW)
Högsta slutkurs: $0.01 den 2025-12-01

Lägsta slutkurs: $0.33 den 2018-10-01
Aktiekurshistorik för Reviva Pharmaceuticals Holdings, Inc. från 2018 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 305.88%
2025 -96.70%
2024 -75.67%
2023 0.82%
2022 134.68%
2021 -39.09%
2020 167.36%
2019 -15.00%
2018 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.27%
KR
$259.89 14.81%
BE